ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,690Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 3734

$1.94M Total Retail Price of All Prescriptions

Rank: 6 out of 3734

960 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 960 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 960 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 22,434 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 1,220 928 1 1
CARVEDILOL 1,121 881 2 30
LEVOTHYROXINE SODIUM 1,023 757 3 2
OMEPRAZOLE 987 695 4 4
AMLODIPINE BESYLATE 783 723 5 5
FUROSEMIDE 743 608 6 7
WARFARIN SODIUM 733 516 7 10
AMLODIPINE BESYLATE-BENAZEPRIL 674 541 10 8 56
METFORMIN HCL 673 506 9 8
LISINOPRIL 536 342 10 3
METOPROLOL TARTRATE 495 392 11 6
HYDROCODONE-ACETAMINOPHEN 454 186 S3 12 12
CLONIDINE HCL 439 340 13 79
CRESTOR 418 277 14 28
MELOXICAM 393 288 15 52
ATORVASTATIN CALCIUM 342 257 16 11
METOPROLOL SUCCINATE 333 199 17 14
DONEPEZIL HCL 322 292 18 25
POTASSIUM CHLORIDE 288 229 19 19
GABAPENTIN 272 178 20 17
NEXIUM 259 206 21 36
CLOPIDOGREL 256 220 22 23
ALLOPURINOL 255 207 23 33
HYDROCHLOROTHIAZIDE 251 206 24 9
ZOLPIDEM TARTRATE 248 92 25 24
SERTRALINE HCL 244 162 26 18
JANUVIA 238 189 27 50
TAMSULOSIN HCL 231 172 28 29
ADVAIR DISKUS 228 142 29 35
COREG CR 211 165 30 334
PANTOPRAZOLE SODIUM 210 171 31 22
DIOVAN 208 177 32 31
PRAVASTATIN SODIUM 205 189 33 15
CITALOPRAM HBR 204 115 34 16
OXYCODONE-ACETAMINOPHEN 204 114 S2 34 51
PLAVIX 202 156 36 39
RANITIDINE HCL 196 151 37 32
DIGOXIN 196 147 37 43
BENAZEPRIL HCL 194 160 39 103
LOVAZA 188 107 40 143
FLUOXETINE HCL 178 100 41 61
NAMENDA 177 177 42 44
ALENDRONATE SODIUM 174 148 43 26
ZETIA 171 147 44 55
SPIRIVA 165 99 45 40
FINASTERIDE 156 138 46 88
JANUMET 156 144 46 180
CYMBALTA 153 62 48 67
LANTUS 153 110 48 54
CARBIDOPA-LEVODOPA 142 127 50 92
ESCITALOPRAM OXALATE 142 112 50 68
VENLAFAXINE HCL ER 140 78 52 84
LOSARTAN POTASSIUM 140 105 52 21
ATENOLOL 137 122 54 13
TORSEMIDE 134 116 55 160
TRAMADOL HCL 133 80 56 20
OXYCODONE HCL 131 36 S2 57 58
AMITRIPTYLINE HCL 130 88 R 58 94
ACTOS 126 103 59 110
ISOSORBIDE MONONITRATE ER 125 117 60 34
CELEBREX 125 84 60 69
RISPERIDONE 121 104 62 62
DILTIAZEM 24HR CD 118 105 63 97
JANTOVEN 115 115 64 76
DIOVAN HCT 115 110 64 72
METHYLPREDNISOLONE 114 78 66 133
PROAIR HFA 112 36 67 83
FLUTICASONE PROPIONATE 111 52 68 46
CIPROFLOXACIN HCL 109 93 69 77
EXFORGE 108 100 70 183
SPIRONOLACTONE 107 68 71 80
ACETAMINOPHEN-CODEINE 107 72 S3 71 123
PAROXETINE HCL 107 86 71 59
VESICARE 107 85 71 157
GLYBURIDE 106 96 R 75 64
LIPITOR 106 86 75 90
PEN NEEDLE 102 73 77 152
PREDNISONE 101 53 78 42
OLANZAPINE 97 97 79 106
ROPINIROLE HCL 95 71 80 118
INSULIN SYRINGE 94 67 81 109
NOVOLOG 93 67 82 112
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 59 82 27
OXYCONTIN 89 15 S2 84 121
AZOR 88 53 85 232
WELCHOL 87 76 86 201
CLOTRIMAZOLE-BETAMETHASONE 87 59 86 135
LOSARTAN-HYDROCHLOROTHIAZIDE 86 70 88 71
FENTANYL 86 67 S2 88 65
RAMIPRIL 86 46 88 91
IBUPROFEN 85 29 91 75
LYRICA 85 47 91 124
TRICOR 85 56 91 93
LOVASTATIN 85 56 91 41
AZITHROMYCIN 83 49 95 38
GLIMEPIRIDE 81 69 96 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 60 97 117
BENICAR 78 55 98 107
AVODART 77 62 99 209
DEXILANT 76 56 100 243
LEVOFLOXACIN 76 60 100 116
NIASPAN 75 52 102 125
DIVALPROEX SODIUM 75 52 102 99
CEFDINIR 74 49 104 300
FAMOTIDINE 73 43 105 60
VYTORIN 72 61 106 163
LABETALOL HCL 72 53 106 176
IPRATROPIUM-ALBUTEROL 71 66 108 98
LEVEMIR FLEXPEN 71 46 108 184
ENABLEX 68 61 110 328
OXYBUTYNIN CHLORIDE ER 68 50 110 141
POLYETHYLENE GLYCOL 3350 68 24 110 53
LANTUS SOLOSTAR 65 50 113 102
NOVOLIN R 64 42 114 215
MECLIZINE HCL 64 44 114 139
VENTOLIN HFA 64 49 114 70
LEXAPRO 63 50 117 236
IBANDRONATE SODIUM 63 29 117 235
ENALAPRIL MALEATE 62 41 119 63
LUNESTA 62 62 119 438
LEVEMIR 59 46 121 202
DOXAZOSIN MESYLATE 58 48 122 100
LOPERAMIDE 56 45 123 251
TRAZODONE HCL 56 34 123 49
METOLAZONE 56 41 123 174
MIRTAZAPINE 55 49 126 45
ABILIFY 55 42 126 159
FENOFIBRATE 53 39 128 81
AMIODARONE HCL 51 19 129 203
HUMALOG 51 39 129 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.